# Grand Pharmaceuticals forms joint venture with Conavi Medical

China Grand Pharmaceutical and Healthcare entered into a joint venture agreement with Canada's Conavi Medical Inc, acquiring exclusive regional distribution rights for Conavi's Foresight ICE and Novasight Hybrid systems in Mainland China, Hong Kong, Macau, and Taiwan for 20 years.

- Type: Partnership
- Announced: 2017-11-15
- Where: Wuhan, China
- Status: announced
- Products: Foresight Intracardiac Echocardiography (ICE) system, Novasight Hybrid Intravascular Imaging system
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [China Grand Pharmaceutical and Healthcare](https://endata.com/companies/28136.md)
- [Conavi Medical Inc](https://endata.com/companies/28137.md) (partner)

## Sources

- [cgeinc.com](https://www.cgeinc.com/en/article/379), 2017-11-15: "By entering into a joint venture with Conavi Medical Inc, Grand Pharmaceuticals acquired exclusive regional distribution rights for Conavi’s “Foresight Intracardiac Echocardiography (ICE)” and “Novasight Hybrid Intravascular Imaging” systems in areas such as Mainland China, Hong Kong, Macau, and Tai"

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.
